Table 2 The prescribing habits of the participants for a patient with schizophrenia
|  | Number of participants N = 72 |
|---|---|
n (%)a | |
Antipsychotic prescribed as first-line treatment | |
 Olanzapine | 33 (45.8) |
 Risperidone | 28 (38.9) |
 Amisulpride | 5 (6.2) |
 Aripiprazole | 2 (2.8) |
 Quetiapine | 0 (0) |
 Conventional neuroleptic | 2 (2.8) |
 No option | 2 (2.80) |
Antipsychotic drug usually prescribed | |
 Olanzapine | 38 (55) |
 Risperidone | 19 (27.5) |
 Amisulpride | 5 (7.2) |
 Aripiprazole | 2 (2.8) |
 Quetiapine | 0 (0) |
 Conventional neuroleptic | 8 (11.5) |
 No option | 0 (0) |
Frequency of combination therapies in a 1st prescription | |
 Never | 7 (9.7) |
 Rarely (once a month) | 19 (26.4) |
 Occasionnlly (once a week) | 14 (19.4) |
 Often (twice to thrice a week) | 27 (37.5) |
 Always | 5 (6.9) |
Frequency of psychotropic drug combinations | |
 Atypical antipsychotic + neuroleptic | 44 (61.1) |
 Atypical antipsychotic + anxiolytic | 19 (26.4) |
 Atypical antipsychotic + thymorégulator | 4 (5.6) |
 Atypical antipsychotic + antidepressant | 1 (1.4) |
 Atypical antipsychotic + hypnotic | 1 (1.4) |
 Two atypical antipsychotics | 1 (1.4) |
 Two neuroleptics | 2 (2.8) |
Frequency of prescribing of neuroleptics long-acting (neuroleptics-LAIs) | |
 Never | 5 (6.9) |
 Rarely (once a month) | 28 (38.9) |
 Occasionally (once a week) | 29 (40.3) |
 Often (twice to thrice a week) | 10 (13.9) |
 Always | 0 (0) |
Frequency of prescribing of second-generation antipsychotic long-acting injectables (SGA-LAIs) | |
 Never | 37 (51.4) |
 Rarely (once a month) | 33 (45.8) |
 Occasionally (once a week) | 2 (2.8) |
 Often (twice to thrice a week) | 0 (0) |
 Always | 0 (0) |